Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-09-08 Sale |
2022-09-12 4:31 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
3,167 | $704.65 | $2,231,624 | 8,091 (Direct) |
View |
2022-09-06 Sale |
2022-09-08 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $582.37 | $58,237 | 19,582 (Direct) |
View |
2022-09-06 Sale |
2022-09-08 4:06 pm |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
6,000 | $581.28 | $3,487,657 | 3,238 (Direct) |
View |
2022-09-01 Sale |
2022-09-02 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $577.62 | $635,382 | 20,282 (Indirect Direct) |
View |
2022-08-16 Sale |
2022-08-17 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
3,513 | $645.49 | $2,267,600 | 72,760 (Indirect Direct) |
View |
2022-08-09 Sale |
2022-08-11 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
15,000 | $620.91 | $9,313,599 | 1,872 (Direct) |
View |
2022-08-04 Sale |
2022-08-08 4:12 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
10,453 | $621.29 | $6,494,319 | 19,682 (Direct) |
View |
2022-08-05 Sale |
2022-08-08 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,782 | $612.61 | $14,569,134 | 63,214 (Indirect Direct) |
View |
2022-08-01 Sale |
2022-08-02 4:28 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $581.53 | $639,683 | 21,382 (Indirect Direct) |
View |
2022-07-01 Sale |
2022-07-05 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $587.76 | $646,536 | 22,481 (Indirect Direct) |
View |
2022-06-01 Sale |
2022-06-03 4:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $669.51 | $736,461 | 23,581 (Indirect Direct) |
View |
2022-05-17 Sale |
2022-05-18 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
3,543 | $663.68 | $2,351,411 | 82,755 (Indirect Direct) |
View |
2022-05-02 Sale |
2022-05-03 5:10 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $650.78 | $65,078 | 22,182 (Direct) |
View |
2022-05-02 Sale |
2022-05-03 5:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $656.97 | $722,667 | 24,660 (Indirect Direct) |
View |
2022-04-08 Sale |
2022-04-11 6:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,187 | $734.61 | $1,606,602 | 43,773 (Indirect Direct) |
View |
2022-04-07 Sale |
2022-04-11 4:41 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
5,114 | $721.1 | $3,687,705 | 19,323 (Indirect Direct) |
View |
2022-04-07 Sale |
2022-04-11 4:38 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $725 | $899,000 | 6,041 (Direct) |
View |
2022-04-05 Sale |
2022-04-07 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
7,114 | $710.05 | $5,051,269 | 682,974 (Indirect Direct) |
View |
2022-04-01 Sale |
2022-04-04 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $701.82 | $701,820 | 25,760 (Indirect Direct) |
View |
2022-04-01 Sale |
2022-04-04 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
5,114 | $690.73 | $3,532,373 | 24,437 (Indirect Direct) |
View |
2022-03-31 Sale |
2022-04-04 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
2,886 | $710.01 | $2,049,089 | 690,088 (Indirect Direct) |
View |
2022-04-01 Sale |
2022-04-04 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $692.81 | $69,281 | 22,282 (Direct) |
View |
2022-03-30 Sale |
2022-04-01 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,431 | $700 | $1,701,700 | 6,082 (Direct) |
View |
2022-03-30 Sale |
2022-04-01 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
28,572 | $700.01 | $20,000,686 | 374,732 (Indirect Direct) |
View |
2022-03-30 Sale |
2022-04-01 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $700 | $868,000 | 7,281 (Direct) |
View |
2022-04-01 Sale |
2022-04-01 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
316 | $695.81 | $219,875 | 32,473 (Indirect Direct) |
View |
2022-03-29 Sale |
2022-03-31 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,930 | $699 | $1,349,070 | 18,514 (Indirect Direct) |
View |
2022-03-29 Sale |
2022-03-30 4:42 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,683 | $687.9 | $1,845,630 | 56,723 (Indirect Direct) |
View |
2022-03-21 Sale |
2022-03-23 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
300 | $693 | $207,900 | 47,773 (Indirect Direct) |
View |
2022-03-21 Sale |
2022-03-23 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
7,439 | $690 | $5,132,910 | 2,269 (Direct) |
View |
2022-03-16 Sale |
2022-03-18 4:14 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,000 | $675 | $1,350,000 | 3,199 (Direct) |
View |
2022-03-16 Sale |
2022-03-18 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
383 | $678.95 | $260,038 | 48,385 (Indirect Direct) |
View |
2022-03-16 Sale |
2022-03-18 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
12,191 | $678.21 | $8,268,075 | 2,269 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 4:19 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $618.37 | $61,837 | 22,382 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $615.39 | $615,390 | 26,760 (Indirect Direct) |
View |
2022-02-25 Sale |
2022-03-01 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
4,000 | $618.25 | $2,473,000 | 28,199 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-08 Exercise |
2022-09-12 4:31 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,279 | $391.92 | 8,091 (Direct) |
View |
2022-09-09 Exercise |
2022-09-12 4:31 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
609 | $376.69 | 8,091 (Direct) |
View |
2022-09-09 Exercise |
2022-09-12 4:31 pm |
N/A 2027-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
3,167 | $0 | 8,091 (Direct) |
View |
2022-09-09 Exercise |
2022-09-12 4:30 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
30,000 | $0 | 38,614 (Direct) |
View |
2022-09-09 Tax Withholding |
2022-09-12 4:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
20,730 | $730.96 | 38,614 (Direct) |
View |
2022-09-09 Exercise |
2022-09-12 4:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
30,000 | $270.43 | 38,614 (Direct) |
View |
2022-09-06 Exercise |
2022-09-08 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
3,784 | $371.4 | 3,238 (Direct) |
View |
2022-09-06 Exercise |
2022-09-08 4:06 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
2,216 | $374.12 | 3,238 (Direct) |
View |
2022-09-06 Exercise |
2022-09-08 4:06 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
6,000 | $0 | 3,238 (Direct) |
View |
2022-09-01 Exercise |
2022-09-02 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $342.93 | 20,282 (Direct) |
View |
2022-09-01 Exercise |
2022-09-02 4:07 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 20,282 (Direct) |
View |
2022-08-15 Tax Withholding |
2022-08-17 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,487 | $634.25 | 72,760 (Direct) |
View |
2022-08-15 Exercise |
2022-08-17 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $179.13 | 72,760 (Direct) |
View |
2022-08-15 Exercise |
2022-08-17 4:04 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $0 | 72,760 (Direct) |
View |
2022-08-09 Exercise |
2022-08-11 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
15,000 | $177.82 | 1,872 (Direct) |
View |
2022-08-09 Exercise |
2022-08-11 4:09 pm |
N/A 2023-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
15,000 | $0 | 1,872 (Direct) |
View |
2022-08-04 Gift |
2022-08-08 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
2,500 | $0 | 19,682 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
2,479 | $380.95 | 19,682 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
4,361 | $374.12 | 19,682 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:12 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
3,613 | $482.68 | 19,682 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:12 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
10,453 | $0 | 19,682 (Direct) |
View |
2022-02-18 Gift |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
335 | $0 | 63,214 (Direct) |
View |
2022-08-04 Tax Withholding |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
71,218 | $613 | 63,214 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:11 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
95,000 | $0 | 63,214 (Direct) |
View |
2022-08-04 Exercise |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
95,000 | $270.43 | 63,214 (Direct) |
View |
2022-08-01 Exercise |
2022-08-02 4:28 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $342.93 | 21,382 (Direct) |
View |
2022-08-01 Exercise |
2022-08-02 4:28 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 21,382 (Direct) |
View |
2022-07-01 Exercise |
2022-07-05 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $342.93 | 22,481 (Direct) |
View |
2022-07-01 Exercise |
2022-07-05 4:03 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 22,481 (Direct) |
View |
2022-06-01 Exercise |
2022-06-03 4:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $342.93 | 23,581 (Direct) |
View |
2022-06-01 Exercise |
2022-06-03 4:00 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 23,581 (Direct) |
View |
2022-05-16 Tax Withholding |
2022-05-18 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,457 | $648.31 | 82,755 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $179.13 | 82,755 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $0 | 82,755 (Direct) |
View |
2022-05-02 Exercise |
2022-05-03 5:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $342.93 | 24,660 (Direct) |
View |
2022-05-02 Exercise |
2022-05-03 5:09 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,100 | $0 | 24,660 (Direct) |
View |
2022-04-08 Exercise |
2022-04-11 6:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
6,000 | $381.92 | 43,773 (Direct) |
View |
2022-04-07 Tax Withholding |
2022-04-11 6:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,175 | $716.09 | 43,773 (Direct) |
View |
2022-04-08 Tax Withholding |
2022-04-11 6:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
6,138 | $736.21 | 43,773 (Direct) |
View |
2022-04-07 Exercise |
2022-04-11 6:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,500 | $399.66 | 43,773 (Direct) |
View |
2022-04-08 Exercise |
2022-04-11 6:01 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
9,500 | $0 | 43,773 (Direct) |
View |
2022-04-08 Exercise |
2022-04-11 4:40 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
2,450 | $555.67 | 48,148 (Direct) |
View |
2022-04-08 Tax Withholding |
2022-04-11 4:40 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,606 | $736.21 | 48,148 (Direct) |
View |
2022-04-08 Exercise |
2022-04-11 4:40 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
7,450 | $0 | 48,148 (Direct) |
View |
2022-04-08 Exercise |
2022-04-11 4:40 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
5,000 | $270.43 | 48,148 (Direct) |
View |
2022-04-07 Exercise |
2022-04-11 4:38 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $380.95 | 6,041 (Direct) |
View |
2022-04-07 Exercise |
2022-04-11 4:38 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $0 | 6,041 (Direct) |
View |
2022-04-01 Exercise |
2022-04-04 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 25,760 (Direct) |
View |
2022-04-01 Exercise |
2022-04-04 4:05 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 25,760 (Direct) |
View |
2022-03-30 Exercise |
2022-04-01 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,431 | $374.12 | 6,082 (Direct) |
View |
2022-03-30 Exercise |
2022-04-01 4:08 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,431 | $0 | 6,082 (Direct) |
View |
2022-03-30 Exercise |
2022-04-01 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $380.95 | 7,281 (Direct) |
View |
2022-03-30 Exercise |
2022-04-01 4:08 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
1,240 | $0 | 7,281 (Direct) |
View |
2022-03-31 Exercise |
2022-04-01 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
2,000 | $555.67 | 53,754 (Direct) |
View |
2022-03-31 Tax Withholding |
2022-04-01 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
8,654 | $700.99 | 53,754 (Direct) |
View |
2022-03-31 Exercise |
2022-04-01 4:07 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
12,000 | $0 | 53,754 (Direct) |
View |
2022-03-31 Exercise |
2022-04-01 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
10,000 | $270.43 | 53,754 (Direct) |
View |
2022-03-31 Tax Withholding |
2022-04-01 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,184 | $700.99 | 32,473 (Direct) |
View |
2022-03-31 Exercise |
2022-04-01 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $399.66 | 32,473 (Direct) |
View |
2022-03-31 Exercise |
2022-04-01 4:07 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $0 | 32,473 (Direct) |
View |
2022-03-29 Exercise |
2022-03-31 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,930 | $374.12 | 18,514 (Direct) |
View |
2022-03-29 Exercise |
2022-03-31 4:04 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,930 | $0 | 18,514 (Direct) |
View |
2022-03-28 Tax Withholding |
2022-03-30 4:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
10,683 | $685.26 | 56,723 (Direct) |
View |
2022-03-28 Exercise |
2022-03-30 4:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,250 | $555.67 | 56,723 (Direct) |
View |
2022-03-28 Exercise |
2022-03-30 4:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
12,000 | $399.66 | 56,723 (Direct) |
View |
2022-03-28 Exercise |
2022-03-30 4:42 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
14,500 | $0 | 56,723 (Direct) |
View |
2022-03-21 Tax Withholding |
2022-03-23 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
312 | $691.31 | 47,773 (Direct) |
View |
2022-03-21 Exercise |
2022-03-23 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $381.92 | 47,773 (Direct) |
View |
2022-03-21 Exercise |
2022-03-23 4:02 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
400 | $0 | 47,773 (Direct) |
View |
2022-03-21 Exercise |
2022-03-23 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
7,439 | $380.95 | 2,269 (Direct) |
View |
2022-03-21 Exercise |
2022-03-23 4:01 pm |
N/A 2028-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
7,439 | $0 | 2,269 (Direct) |
View |
2022-03-16 Exercise |
2022-03-18 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,000 | $391.92 | 3,199 (Direct) |
View |
2022-03-16 Exercise |
2022-03-18 4:14 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,000 | $0 | 3,199 (Direct) |
View |
2022-03-17 Exercise |
2022-03-18 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
365 | $381.92 | 48,385 (Direct) |
View |
2022-03-17 Exercise |
2022-03-18 4:08 pm |
N/A 2026-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
365 | $0 | 48,385 (Direct) |
View |
2022-03-17 Tax Withholding |
2022-03-18 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
286 | $682.5 | 48,385 (Direct) |
View |
2022-03-16 Exercise |
2022-03-18 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
4,361 | $374.12 | 2,269 (Direct) |
View |
2022-03-17 Exercise |
2022-03-18 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
7,830 | $376.69 | 2,269 (Direct) |
View |
2022-03-16 Exercise |
2022-03-18 4:05 pm |
N/A 2030-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
12,191 | $0 | 2,269 (Direct) |
View |
2022-01-04 Gift |
2022-03-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
338 | $0 | 530,310 (Indirect) |
View |
2022-03-14 Exercise |
2022-03-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
75,000 | $179.13 | 530,310 (Direct) |
View |
2022-03-14 Tax Withholding |
2022-03-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
48,103 | $655.29 | 530,310 (Direct) |
View |
2022-03-14 Exercise |
2022-03-15 4:01 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
75,000 | $0 | 530,310 (Direct) |
View |
2022-03-01 Exercise |
2022-03-03 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 26,760 (Direct) |
View |
2022-03-01 Exercise |
2022-03-03 4:07 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 26,760 (Direct) |
View |